Lexaria Bioscience - Warrants (11/01/2026) Profit Margin

As of the most recent data (May 2026), LEXXW shows a profit margin of -3985.58%. That compares with -1849.39% in the prior-year period — down 115.5% year over year. That is below the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LEXXW's profit margin is now -3985.58% (was -1849.39%) — a 115.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lexaria Bioscience - Warrants (11/01/2026) is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. Lexaria Bioscience - Warrants (11/01/2026) is at -3985.58%, which is lower that average. That is roughly 27884.2% below the sector mean. Use the comparison chart on this page to see how LEXXW stacks up against individual peers as well.

That compares with -1849.39% in the prior-year period — down 115.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Lexaria Bioscience - Warrants (11/01/2026) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Lexaria Bioscience - Warrants (11/01/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -3985.58%) with ownership activity and broader fundamentals.